Laurence Marton's Insider Trades & SAST Disclosures
Laurence Marton's most recent trade in RenovoRx Inc was a trade of 20,480 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Laurence Marton.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RenovoRx Inc | Laurence J. Marton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 20,480 | 0 | - | - | Stock Option (right to buy) | |
| RenovoRx Inc | Laurence J. Marton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 02 May 2025 | 20,480 | 66,164 | - | 0.2 | 3,072 | Common Stock |
| RenovoRx Inc | Laurence J. Marton | Director | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 08 Apr 2025 | 12,050 | 45,684 | - | 0.8 | 10,218 | Common Stock |
| RenovoRx Inc | Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
| RenovoRx Inc | Marton Laurence J. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 8,196 | 33,634 | - | - | Common Stock | |
| RenovoRx Inc | J. Marton Laurence | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 8,196 | 8,196 | - | - | Warrants | |
| RenovoRx Inc | Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
| RenovoRx Inc | Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock Option (right to buy) | |
| RenovoRx Inc | Laurence Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 11,154 | 11,154 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges